Douglas McNair MD PhD, Sr. Vice President and Research Director, Cerner Corporation, Kansas City, reviews proven methodologies that you can use now to evaluate your own ADE reduction relative to the application of clinical IT. Quality and Safety analysts, researchers, and biostatisticians will benefit from this discussion about methods for measuring rates and “safety-improvement intervention-related” progression. These can be modeled quantitatively and predicted as you go — it is not necessary to wait until the final conclusion of a study to do the measuring, modeling and interpretation. The methods may be unfamiliar to healthcare, but they have a 50+ year history of successful use in other safety-critical areas, including military and life-critical implantable devices.
ReliaSoft RGA 6: Standard and PRO Editions